206 related articles for article (PubMed ID: 25768730)
1. Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway.
Yu Q; Lou XM; He Y
PLoS One; 2015; 10(3):e0120855. PubMed ID: 25768730
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
3. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
4. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.
Kim TG; Byamba D; Wu WH; Lee MG
Exp Dermatol; 2011 Oct; 20(10):855-7. PubMed ID: 21824198
[TBL] [Abstract][Full Text] [Related]
5. The RORγt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients.
Kaneko S; Kondo Y; Yokosawa M; Furuyama K; Segawa S; Tsuboi H; Kanamori A; Matsumoto I; Yamazaki M; Sumida T
Mod Rheumatol; 2018 Sep; 28(5):814-825. PubMed ID: 29251019
[TBL] [Abstract][Full Text] [Related]
6. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells.
Hirata T; Osuga Y; Takamura M; Kodama A; Hirota Y; Koga K; Yoshino O; Harada M; Takemura Y; Yano T; Taketani Y
Endocrinology; 2010 Nov; 151(11):5468-76. PubMed ID: 20881253
[TBL] [Abstract][Full Text] [Related]
8. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
9. Stromal Fibroblasts Induce CCL20 through IL6/C/EBPβ to Support the Recruitment of Th17 Cells during Cervical Cancer Progression.
Walch-Rückheim B; Mavrova R; Henning M; Vicinus B; Kim YJ; Bohle RM; Juhasz-Böss I; Solomayer EF; Smola S
Cancer Res; 2015 Dec; 75(24):5248-59. PubMed ID: 26631268
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
[TBL] [Abstract][Full Text] [Related]
11. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.
Kulkarni N; Meitei HT; Sonar SA; Sharma PK; Mujeeb VR; Srivastava S; Boppana R; Lal G
J Autoimmun; 2018 Mar; 88():121-130. PubMed ID: 29126851
[TBL] [Abstract][Full Text] [Related]
12. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver.
Oo YH; Banz V; Kavanagh D; Liaskou E; Withers DR; Humphreys E; Reynolds GM; Lee-Turner L; Kalia N; Hubscher SG; Klenerman P; Eksteen B; Adams DH
J Hepatol; 2012 Nov; 57(5):1044-51. PubMed ID: 22796894
[TBL] [Abstract][Full Text] [Related]
13. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
[TBL] [Abstract][Full Text] [Related]
14. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
15. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
Ghadjar P; Rubie C; Aebersold DM; Keilholz U
Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
[TBL] [Abstract][Full Text] [Related]
17. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.
Turner JE; Paust HJ; Steinmetz OM; Peters A; Riedel JH; Erhardt A; Wegscheid C; Velden J; Fehr S; Mittrücker HW; Tiegs G; Stahl RA; Panzer U
J Am Soc Nephrol; 2010 Jun; 21(6):974-85. PubMed ID: 20299360
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptors in the pathogenesis and therapy of psoriasis.
Mabuchi T; Chang TW; Quinter S; Hwang ST
J Dermatol Sci; 2012 Jan; 65(1):4-11. PubMed ID: 22177422
[TBL] [Abstract][Full Text] [Related]
19. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
[TBL] [Abstract][Full Text] [Related]
20. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
